Ledger.Open graph →
SEC Form D · filed October 14, 2022

Neuraptive Therapeutics, Inc

Offering
$38.1M
Sold
$19.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PHILADELPHIA, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Ivan S. Gergel · Philadelphia, PADirectorDavid S. Jackson · Philadelphia, PADirectorRandy S. Hubbell · Philadelphia, PADirectorRobert S. Radie · Philadelphia, PAExec · DirectorGreg S. Parekh · Philadelphia, PADirectorDavid S. Pierce · Philadelphia, PADirectorEvan S. Tzanis · Philadelphia, PAExecRandy S. Hubbell · Philadelphia, PADirectorRobert S. Radie · Philadelphia, PAExec · DirectorGreg S. Parekh · Philadelphia, PADirectorDavid S. Pierce · Philadelphia, PADirectorIvan S. Gergel · Philadelphia, PADirectorDavid S. Jackson · Philadelphia, PADirectorEvan S. Tzanis · Philadelphia, PAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗